Biomed Diagnostics

Biomed Diagnostics is a specialized diagnostics company that develops and commercializes innovative, self-contained culture systems designed to streamline microbiology testing. Its flagship InTray® and InPouch® products consolidate specimen collection, transport, incubation, and microscopic analysis into single, contamination-resistant devices, serving human health, veterinary, and food safety sectors. Acquired by DCN Dx, the company operates with a proven commercial model, leveraging ISO 13485 certification and regulatory clearances (FDA, CE IVD) to address global needs for portable, reliable diagnostic tools. Its business focuses on replacing traditional, multi-step culture methods with integrated solutions that reduce complexity and improve efficiency in both lab and point-of-care environments.

Proprietary self-contained culture systems (InTray®, InPouch®) that integrate specimen collection, selective media, incubation, and direct microscopic analysis into single-use, contamination-resistant devices.

Competes with large IVD companies (e.g., Becton Dickinson, bioMérieux) offering traditional culture media and automated systems, as well as niche players in point-of-care microbiology. Key differentiation is the all-in-one, contamination-resistant format of its InTray®/InPouch® systems.